PRME 8-K: SEC filing
Prime Medicine
Filed with the SEC on · accession 0001628280-26-072713
PRME filed a 8-K (current report) with the SEC on Nov 10, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Summary of the filing
Prime Medicine announced preliminary unaudited cash, cash equivalents, and short-term investments of approximately $61.2 million as of September 30, 2026, excluding restricted cash of approximately $13.7 million, and posted an updated corporate presentation to its website.
Key details
✦ Ask GOAX AI about this filing — what it means for PRME, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for PRME?
Click hereFrequently asked questions
What did PRME file with the SEC on Nov 10, 2026?
PRME filed a 8-K (SEC filing). Prime Medicine announced preliminary unaudited cash, cash equivalents, and short-term investments of approximately $61.2 million as of September 30, 2026, excluding restricted cash of approximately $13.7 million, and posted an updated corporate presentation to its website.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other PRME SEC filings
Get alerts when PRME files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days